AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19822590 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided imagery treatment effects maintained for 6 months
Number of subjects: 34
Study 15190043 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flavonoid dark chocolate (213 mg procyanidins, 46 mg epicatechin)
Number of subjects: 21
Study 15190043 — intervention group
Group type: COMPARATOR
Intervention: Low-flavonoid dark chocolate (46 g, 1.6 oz)
Number of subjects: 21
Study 15190043 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flavonoid dark chocolate
Number of subjects: 21
Study 15190043 — intervention group
Group type: COMPARATOR
Intervention: Low-flavonoid dark chocolate
Number of subjects: 21
Study 11735841 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus a 15-session group cognitive therapy prevention program
Number of subjects: 94
Study 11735841 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 94
Study 9470494 — intervention group
Group type: EXPERIMENTAL
Intervention: DCPD dentifrices
Number of subjects: 0
Study 9470494 — intervention group
Group type: EXPERIMENTAL
Intervention: DCPD/fluoride dentifrice
Number of subjects: 0
Study 8192116 — intervention group
Group type: EXPERIMENTAL
Intervention: Two doses of ondansetron (0.15 mg/kg) with dexamethasone (20 mg)
Number of subjects: 44
Study 8192116 — intervention group
Group type: EXPERIMENTAL
Intervention: Three doses of ondansetron (0.15 mg/kg) with dexamethasone (20 mg)
Number of subjects: 44
Study 8192116 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of ondansetron and dexamethasone
Number of subjects: 44
Study 2854886 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide and ACTH
Number of subjects: 16
Study 2854886 — intervention group
Group type: COMPARATOR
Intervention: ACTH alone
Number of subjects: 16
Study 31983034 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined oral contraceptive (COC) users
Number of subjects: 62
Study 31983034 — intervention group
Group type: COMPARATOR
Intervention: Non-COC users
Number of subjects: 62
Study 31983034 — intervention group
Group type: EXPERIMENTAL
Intervention: Very low dose COCs (20 mcg EE)
Number of subjects: 62
Study 31310442 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytokine-based prediction models using IL-6, IL-27, and CRP
Number of subjects: 344
Study 31310442 — intervention group
Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP)
Number of subjects: 344
Study 27926561 — intervention group
Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate ointment (twice daily for 8 weeks)
Number of subjects: 80
Study 27926561 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous posterior tibial nerve stimulation (30-minute session 2 days per week for 8 weeks)
Number of subjects: 80
Study 26321186 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (40 mg/day)
Number of subjects: 34
Study 26321186 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 23525894 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-7 (180 μg MK-7/day)
Number of subjects: 244
Study 23525894 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 244
Study 21477878 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 0
Study 21477878 — intervention group
Group type: COMPARATOR
Intervention: Glipizide
Number of subjects: 0
Study 19682342 — intervention group
Group type: EXPERIMENTAL
Intervention: IV ferric carboxymaltose (≤1000 mg over 15 min, repeated weekly)
Number of subjects: 477
Study 19682342 — intervention group
Group type: COMPARATOR
Intervention: Ferrous sulfate (325 mg orally thrice daily for 6 weeks)
Number of subjects: 477
Study 16769917 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD therapy
Number of subjects: 1218
Study 16769917 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-chamber ICD
Number of subjects: 1218
Study 16769917 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-chamber ICD
Number of subjects: 1218
Study 16769917 — intervention group
Group type: EXPERIMENTAL
Intervention: Life-prolonging therapy from the ICD
Number of subjects: 1218
Study 15128007 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy following surgery
Number of subjects: 925
Study 15128007 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 925
Study 15128007 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 925
Study 11795434 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride (5-alpha-reductase inhibitor)
Number of subjects: 0
Study 11795434 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium and Vitamin E
Number of subjects: 0
Study 11795434 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation and diet modification
Number of subjects: 0
Study 9397979 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactulose (45 mL/d) for 8 weeks
Number of subjects: 75
Study 9397979 — intervention group
Group type: COMPARATOR
Intervention: Nontreated (control group)
Number of subjects: 75
Study 7535496 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusion therapy
Number of subjects: 0
Study 3653083 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac
Number of subjects: 63
Study 3653083 — intervention group
Group type: EXPERIMENTAL
Intervention: Pethidine
Number of subjects: 63
Study 3653083 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 30905182 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive correction training (40 sessions, 30 minutes each, 5 sessions per week)
Number of subjects: 70
Study 30905182 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 70
Study 29774412 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid constructs (sublaminar bands on concave side and pedicle screw)
Number of subjects: 37
Study 29774412 — intervention group
Group type: COMPARATOR
Intervention: Pedicle screws only
Number of subjects: 37
Study 29774412 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid constructs (sublaminar bands)
Number of subjects: 37
Study 29774412 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 37
Study 27058907 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication Therapy Management review and CVD risk assessment and education
Number of subjects: 723
Study 27058907 — intervention group
Group type: COMPARATOR
Intervention: Usual care (usual pharmacist care with no specific intervention)
Number of subjects: 723
Study 25504176 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyadic music therapy intervention (10 weekly sessions)
Number of subjects: 18
Study 25504176 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 18
Study 22824755 — intervention group
Group type: EXPERIMENTAL
Intervention: Fermented papaya preparation (FPP) 9g/day (4.5g twice a day sublingually) for 6 weeks
Number of subjects: 90
Study 22824755 — intervention group
Group type: EXPERIMENTAL
Intervention: Fermented papaya preparation (FPP)
Number of subjects: 90
Study 22824755 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 20846428 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly CCQ assessment
Number of subjects: 121
Study 18663298 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine varnish
Number of subjects: 0
Study 15956086 — intervention group
Group type: EXPERIMENTAL
Intervention: beta-endorphin (250 mug/h)
Number of subjects: 23
Study 15956086 — intervention group
Group type: COMPARATOR
Intervention: naloxone (8 mg) preceding beta-endorphin infusion
Number of subjects: 23
Study 12141468 — intervention group
Group type: COMPARATOR
Intervention: Filtered dialysate
Number of subjects: 37
Study 12141468 — intervention group
Group type: EXPERIMENTAL
Intervention: All four modalities of HD (F 60, F 500S, Tricea 150G, Tricea 150Gf)
Number of subjects: 37
Study 9564059 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 exposure during operative laparoscopy
Number of subjects: 28
Study 9564059 — intervention group
Group type: COMPARATOR
Intervention: Control group (laparotomy)
Number of subjects: 28
Study 8605417 — intervention group
Group type: EXPERIMENTAL
Intervention: Bony decompression
Number of subjects: 6
Study 8605417 — intervention group
Group type: COMPARATOR
Intervention: Diskectomy
Number of subjects: 6
Study 2692962 — intervention group
Group type: EXPERIMENTAL
Intervention: HRP112 (depot‐medroxyprogesterone acetate, 25 mg and estradiol cypionate, 5 mg)
Number of subjects: 2320
Study 2692962 — intervention group
Group type: EXPERIMENTAL
Intervention: HRP102 (norethisterone enantate, 50 mg and estradiol valerate, 5 mg)
Number of subjects: 2320
Study 48894 — intervention group
Group type: EXPERIMENTAL
Intervention: Procainamide (500 mg, 4-hourly)
Number of subjects: 60
Study 48894 — intervention group
Group type: EXPERIMENTAL
Intervention: Mexiletine (250 mg, 8-hourly)
Number of subjects: 60
Study 48894 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 29148088 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive intervention (four weekly group sessions and two motivational follow-up calls)
Number of subjects: 208
Study 29148088 — intervention group
Group type: COMPARATOR
Intervention: Individual standardized brief counseling on healthy lifestyles
Number of subjects: 208
Study 26828618 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid 5 mg
Number of subjects: 17
Study 26828618 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 24801818 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive services of a Certified Child Life Specialist (CCLS)
Number of subjects: 137
Study 24801818 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (no child life services)
Number of subjects: 137
Study 22856637 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/day of jet‐nebulized budesonide inhalation suspension (BIS)
Number of subjects: 53
Study 22856637 — intervention group
Group type: COMPARATOR
Intervention: 40-60 mg/day of cromolyn sodium inhalation suspension (CIS)
Number of subjects: 53
Study 20070953 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based self-help writing intervention
Number of subjects: 757
Study 20070953 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control condition
Number of subjects: 757
Study 18701019 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive therapy
Number of subjects: 220
Study 18701019 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 220
Study 15934131 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise therapy
Number of subjects: 759
Study 15934131 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly telephone contact
Number of subjects: 759
Study 15934131 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise therapy and telephone contact
Number of subjects: 759
Study 15934131 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 759
Study 12870698 — intervention group
Group type: COMPARATOR
Intervention: Type I diabetic subjects
Number of subjects: 0
Study 12870698 — intervention group
Group type: COMPARATOR
Intervention: Type II diabetic subjects
Number of subjects: 0
Study 12870698 — intervention group
Group type: EXPERIMENTAL
Intervention: Control subjects
Number of subjects: 0
Study 11383809 — intervention group
Group type: EXPERIMENTAL
Intervention: Water seal
Number of subjects: 140
Study 11383809 — intervention group
Group type: COMPARATOR
Intervention: Suction
Number of subjects: 140
Study 11383809 — intervention group
Group type: EXPERIMENTAL
Intervention: Water seal (after randomization ended)
Number of subjects: 140
Study 11383809 — intervention group
Group type: EXPERIMENTAL
Intervention: Water seal (with leaks 4/7 or greater)
Number of subjects: 140
Study 9183510 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based relapse prevention (G-RP)
Number of subjects: 32
Study 9183510 — intervention group
Group type: COMPARATOR
Intervention: Individually based relapse prevention (I-RP)
Number of subjects: 32
Study 9183510 — intervention group
Group type: EXPERIMENTAL
Intervention: Relapse prevention treatment (both formats)
Number of subjects: 32
Study 1586782 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet A (fat reduced diet rich in soluble dietary fibre, antioxidant vitamins, and minerals, advised to eat more fruit, vegetables, nuts, and grain products)
Number of subjects: 505
Study 1586782 — intervention group
Group type: COMPARATOR
Intervention: Diet B (fat reduced diet)
Number of subjects: 505
Study 3886398 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 10
Study 3886398 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 31350924 — intervention group
Group type: EXPERIMENTAL
Intervention: mCAF + ADMG
Number of subjects: 22
Study 31350924 — intervention group
Group type: COMPARATOR
Intervention: CAF + ADMG
Number of subjects: 22
Study 29405780 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein diet (HP: 2.5 g·kg‐1·day‐1; n=8)
Number of subjects: 17
Study 29405780 — intervention group
Group type: COMPARATOR
Intervention: Low-protein diet (LP: 0.9 g·kg‐1·day‐1; n=9)
Number of subjects: 17
Study 26879181 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised acupuncture (IA)
Number of subjects: 164
Study 26879181 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture (SA)
Number of subjects: 164
Study 24112515 — intervention group
Group type: EXPERIMENTAL
Intervention: Nevirapine XR formulation
Number of subjects: 800
Study 23148455 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative mood
Number of subjects: 0
Study 23148455 — intervention group
Group type: COMPARATOR
Intervention: Positive mood
Number of subjects: 0
Study 23148455 — intervention group
Group type: EXPERIMENTAL
Intervention: High plausibility messages under sad mood
Number of subjects: 0
Study 23148455 — intervention group
Group type: EXPERIMENTAL
Intervention: Fidgety nonverbal cues under happy mood
Number of subjects: 0
Study 20467878 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine with 50 microg fentanyl (group BF)
Number of subjects: 90
Study 20467878 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine with 4 mg dexamethasone (group BD)
Number of subjects: 90
Study 20467878 — intervention group
Group type: COMPARATOR
Intervention: Epidural plain bupivacaine 0.25% (control group B)
Number of subjects: 90
Study 17052369 — intervention group
Group type: EXPERIMENTAL
Intervention: Re‐operative thyroid surgery (group one)
Number of subjects: 125
Study 17052369 — intervention group
Group type: COMPARATOR
Intervention: Control group (group two)
Number of subjects: 125
Study 16034009 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg per day
Number of subjects: 1255
Study 16034009 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1255
Study 11570653 — intervention group
Group type: EXPERIMENTAL
Intervention: Education intervention
Number of subjects: 252
Study 11570653 — intervention group
Group type: COMPARATOR
Intervention: Peer discussion intervention
Number of subjects: 252
Study 11570653 — intervention group
Group type: COMPARATOR
Intervention: Education plus peer discussion intervention
Number of subjects: 252
Study 11570653 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 252
Study 9646062 — intervention group
Group type: EXPERIMENTAL
Intervention: Amorphous erythromycin ethylsuccinate (500 mg)
Number of subjects: 12
Study 9646062 — intervention group
Group type: EXPERIMENTAL
Intervention: Crystalline erythromycin ethylsuccinate (1000 mg)
Number of subjects: 12
Study 9646062 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 7884020 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (40 mg)
Number of subjects: 5
Study 7884020 — intervention group
Group type: COMPARATOR
Intervention: Cocaine (20 mg and 40 mg)
Number of subjects: 5
Study 7884020 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine and cocaine
Number of subjects: 5
Study 3220956 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg methylphenidate
Number of subjects: 12
Study 3220956 — intervention group
Group type: EXPERIMENTAL
Intervention: 12.5 mg meclizine
Number of subjects: 12
Study 3220956 — intervention group
Group type: EXPERIMENTAL
Intervention: both methylphenidate and meclizine
Number of subjects: 12
Study 3220956 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study 1678703 — intervention group
Group type: EXPERIMENTAL
Intervention: NEMG (neck electromyography) recordings
Number of subjects: 10
Study 1678703 — intervention group
Group type: COMPARATOR
Intervention: FEMG (frontal electromyography) recordings
Number of subjects: 10
Study 73796 — intervention group
Group type: EXPERIMENTAL
Intervention: Addition of 16 g guar and 10 g pectin to the control meal
Number of subjects: 11
Study 73796 — intervention group
Group type: COMPARATOR
Intervention: Control meal containing 106 g carbohydrate
Number of subjects: 11
Study 31800368 — intervention group
Group type: EXPERIMENTAL
Intervention: Video counseling series provided through Zoom
Number of subjects: 0
Study 30729735 — intervention group
Group type: EXPERIMENTAL
Intervention: 4S soothing techniques (swaddling, holding at side or stomach position, shushing‐white noise, swinging)
Number of subjects: 42
Study 29236097 — intervention group
Group type: EXPERIMENTAL
Intervention: I-PASS
Number of subjects: 4
Study 29236097 — intervention group
Group type: EXPERIMENTAL
Intervention: Policy mandate on task accountability
Number of subjects: 4
Study 29236097 — intervention group
Group type: EXPERIMENTAL
Intervention: Plan-Do-Study-Act (PDSA)
Number of subjects: 4
Study 29236097 — intervention group
Group type: COMPARATOR
Intervention: Didactics
Number of subjects: 4
Study 25884899 — intervention group
Group type: EXPERIMENTAL
Intervention: target‐lesion SYNTAX score (tSS)
Number of subjects: 420
Study 25884899 — intervention group
Group type: EXPERIMENTAL
Intervention: tSS
Number of subjects: 420
Study 23601001 — intervention group
Group type: EXPERIMENTAL
Intervention: Irrigated radiofrequency current (RFC)
Number of subjects: 99
Study 23601001 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoballoon (CB)
Number of subjects: 99
Study 23601001 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser balloon (LB)
Number of subjects: 99
Study 23601001 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 99
Study 21741700 — intervention group
Group type: EXPERIMENTAL
Intervention: Formal one-to-one pelvic floor muscle training (4 sessions over 3 months)
Number of subjects: 390
Study 21741700 — intervention group
Group type: COMPARATOR
Intervention: Standard care and lifestyle advice only (Control)
Number of subjects: 390
Study 21741700 — intervention group
Group type: EXPERIMENTAL
Intervention: Both trials (combined)
Number of subjects: 390
Study 19627897 — intervention group
Group type: EXPERIMENTAL
Intervention: Laterally wedged insole alone
Number of subjects: 14
Study 19627897 — intervention group
Group type: COMPARATOR
Intervention: Concurrent use of ankle support with wedged insole
Number of subjects: 14
Study 17119140 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard open diskectomy
Number of subjects: 501
Study 17119140 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative treatment individualized to the patient
Number of subjects: 501
Study 17119140 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment groups (surgery and nonoperative)
Number of subjects: 501
Study 15149345 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 1513
Study 15149345 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1513
Study 15149345 — intervention group
Group type: EXPERIMENTAL
Intervention: High baseline albuminuria (> or =3.0 g/g creatinine)
Number of subjects: 1513
Study 11553243 — intervention group
Group type: EXPERIMENTAL
Intervention: Right lateral position
Number of subjects: 34
Study 11553243 — intervention group
Group type: COMPARATOR
Intervention: Left lateral position
Number of subjects: 34
Study 11553243 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 34
Study 9559471 — intervention group
Group type: EXPERIMENTAL
Intervention: AcrySof IOL
Number of subjects: 90
Study 9559471 — intervention group
Group type: COMPARATOR
Intervention: PMMA IOL
Number of subjects: 90
Study 9559471 — intervention group
Group type: COMPARATOR
Intervention: Silicone IOL
Number of subjects: 90
Study 7878556 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory pressure support 18 cm H2O
Number of subjects: 12
Study 7878556 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure support 18 cm H2O + positive end expiratory pressure (PEEP) 6 cm H2O (IPAP+EPAP)
Number of subjects: 12
Study 7878556 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure (CPAP) 8 cm H2O
Number of subjects: 12
Study 7878556 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume cycled NIPPV
Number of subjects: 12
Study 7878556 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 12
Study 3064454 — intervention group
Group type: EXPERIMENTAL
Intervention: Punctate transcutaneous electric nerve stimulation (PuTENS)
Number of subjects: 740
Study 3064454 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 740
Study 3064454 — intervention group
Group type: COMPARATOR
Intervention: Medicamentously controlled studies
Number of subjects: 740
Study 28930284 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 IU)
Number of subjects: 10
Study 28930284 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 28064349 — intervention group
Group type: EXPERIMENTAL
Intervention: Salivary exposure for 30 min
Number of subjects: 20
Study 28064349 — intervention group
Group type: EXPERIMENTAL
Intervention: Salivary exposure for 1 h
Number of subjects: 20
Study 28064349 — intervention group
Group type: EXPERIMENTAL
Intervention: Salivary exposure for 2 h
Number of subjects: 20
Study 28064349 — intervention group
Group type: EXPERIMENTAL
Intervention: Salivary exposure for 12 h
Number of subjects: 20
Study 28064349 — intervention group
Group type: COMPARATOR
Intervention: Control group (no salivary exposure)
Number of subjects: 20
Study 25361537 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised psycho-education and 24-month preventive monitoring
Number of subjects: 238
Study 25361537 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 238
Study 23474436 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride (5mg/day)
Number of subjects: 53